Store within the original packaging
doi: 10.3389/fendo.2025.1569468 Received 31 January 2025 Accepted 27 May 2025 Published 18 June 2025 Corrected 02 October 2025 Volume 16 - 2025 Edited by Chanan Meydan, Rabin Medical Center, Israel Reviewed by Michail Kokkorakis, Harvard Medical School, United States Danny Sugimoto, Cedar Crosse Research Center, United States Updates Copyright 2025 Steenackers, Toumassian, Deleus, Mertens, Lannoo, Pazmino, van Laar, Van der Schueren and Vangoitsenhoven
It is essential to determine whether changes are related to the medication, the process of weight loss, an underlying condition, or another factor
The misuse of weight-loss drugs without clinical oversight can lead to severe health complications
Continental Hospitals GLP-1
People taking Contrave are at least 2 to 3 times more likely to lose a meaningful amount of weight